Related Experiment Video

Updated: Jul 15, 2026

Assessing the Effects of Music Listening on Psychobiological Stress in Daily Life
07:17

Assessing the Effects of Music Listening on Psychobiological Stress in Daily Life

Published on: February 2, 2017

The impact of cardiovascular medication use on patients' daily lives: a cross-sectional study

Danielle M van der Laan1, Petra J M Elders2, Christel C L M Boons3

  • 1Department of Clinical Pharmacology and Pharmacy and the Amsterdam Public Health Research Institute, VU University Medical Center, De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands. d.vanderlaan1@vumc.nl.

International Journal of Clinical Pharmacy
|February 14, 2018
PubMed

Insights

Managing multiple long-term cardiovascular medications impacts patients daily lives, causing burden. Adherence levels did not significantly alter this medication-related burden experienced by patients.

Area of Science:

  • Pharmacology
  • Patient Care
  • Chronic Disease Management

Background:

  • Managing multiple long-term medications for chronic diseases poses a significant burden on patients.
  • Limited research exists on the specific impact of this medication management on patients' daily lives.

Purpose of the Study:

  • To explore the impact of cardiovascular medication on various daily life aspects.
  • To compare these impacts between patients adherent and non-adherent to their medication regimens.

Main Methods:

  • Cross-sectional study involving patients aged 45 years and older using cardiovascular medication.
  • Two equally sized groups of adherent and non-adherent patients were selected based on pharmacy refill data.
  • The Living with Medicines Questionnaire was used to measure the impact of medication use on daily life.

Main Results:

  • 196 patients participated, with 96 identified as non-adherent.
  • Significant patient burden was reported concerning acceptance of long-term use, concerns, dissatisfaction, interference with daily/social life, and healthcare provider interactions.
  • No statistically significant differences in daily life impact were found between adherent and non-adherent patient groups.

Conclusions:

  • Healthcare providers must recognize the substantial impact of multiple long-term medications on patients' daily lives.
  • Reducing medication-related burden requires enhancing patient-provider relationships and providing tailored information.
  • Improved support can facilitate better integration of long-term medication use into patients' daily routines.

Keywords:
Cardiovascular medicationMedication non-adherenceMedication-related burdenPatients’ daily livesThe Netherlands

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies15:00

Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies

Published on: February 3, 2023

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...